IMAC Holdings, Inc. Announces Opening Enrollment in Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
November 05, 2020 09:00 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn, Nov. 05, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings, Inc. Adds Three Distinguished Executives to its Board of Directors
November 02, 2020 09:25 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Nov. 02, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Regeneration Centers Sells Lexington Property for $1.3M in Sale-Leaseback Transaction
July 27, 2020 10:30 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., July 27, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (the “Company” or “IMAC”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Establishes Dedicated Corporate Accounts Division; Broadens Positioning of Product Offerings to Provide Innovative Medical Advancements and Care
March 06, 2019 07:30 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., March 06, 2019 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of Innovative Medical Advancements and Care, specializing in regenerative rehabilitation...